Investing Profile

Brendan Bulik-Sullivan

VCInvestor
General Partner at GV (Google Ventures)
gv.com/team/brendan-bulik-sul...San Francisco, California
Photo of Brendan Bulik-Sullivan, General Partner at GV (Google Ventures)
Your Intro Paths to Brendan Bulik-Sullivan

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Networks Brendan is a member of
University of California, Berkeley Network
501 CONNECTIONS
GV Network
32 CONNECTIONS
VU University Amsterdam Network
29 CONNECTIONS
GV (Google Ventures) Network
26 CONNECTIONS
Broad Institute of MIT and Harvard Network
22 CONNECTIONS

Find Brendan Bulik-Sullivan on

cb
Current Investing Position
GV (Google Ventures) General Partner
Investment Range
$250K - $50.0M
Sweet Spot
$25.0M
Investments On Record
17
Current Fund Size
$8B

Brendan Bulik-Sullivan is on these Sector & Stage Rankings

Brendan Bulik-Sullivan's Investments On Record (11)

CompanyStageDateRound SizeTotal Raised
Metsera
Series BNov 2024$220M
Series AApr 2024$290M
$510M
Co-investors: Sherry Chao (GV (Google Ventures)), Kristina Burow (ARCH Venture Partners), Paul Berns (ARCH Venture Partners), Nimish Shah (Venrock)
Santa Ana Bio
Series BJun 2024$130M
Series AFeb 2023$43M
$170M
Co-investors: Sherry Chao (GV (Google Ventures)), Vineeta Agarwala (Andreessen Horowitz), Christine Borowski (Access Biotechnology), Peter Emtage (Versant Ventures), Jerel Davis (Versant Ventures), Shinichiro Fuse
Areteia Therapeutics
Series AFeb 2024$75M
Series AJul 2022$350M
$430M
Co-investors: Adam Koppel (Bain Capital Life Sciences), Paul Berns (ARCH Venture Partners)
Comanche Biopharma
Series BJan 2024$75M
Series AMay 2023$36M
$110M
Co-investors: Scott Gottlieb (New Enterprise Associates (NEA)), David Grayzel (Atlas Venture)
Bitterroot Bio
Series AJun 2023$150M
$150M
Co-investors: Anthony Philippakis (GV (Google Ventures)), Steven Gillis (ARCH Venture Partners), Andrew ElBardissi (Deerfield Management)
Vicinitas Therapeutics
Series AJul 2022$65M
$65M
Co-investors: Jorge Conde (Andreessen Horowitz), Cameron Wheeler (Deerfield Management)
Ventus Therapeutics
Series CFeb 2022$140M
Series BApr 2021$100M
Series AMay 2020$60M
$300M
Co-investors: Jerel Davis (Versant Ventures)
Sonoma Biotherapeutics
Series BAug 2021$270M
$340M
Co-investors: Krishna Yeshwant (GV (Google Ventures)), Robert Nelsen (ARCH Venture Partners)

Brendan Bulik-Sullivan's Experience

Statistical Genetics Broad Institute of MIT and HarvardPresent
Machine Learning Gritstone OncologyPresent
Board of Directors Maze TherapeuticsPresent
Board of Directors Ventus Therapeutics Part-timePresent
Partner GVPresent
General Partner GV (Google Ventures)Present

Brendan Bulik-Sullivan's Education

Vrije Universiteit Amsterdam (VU Amsterdam) Doctor of Philosophy (PhD) Statistical Genetics
VU University Amsterdam Doctor of Philosophy (PhD) Statistical Genetics
University of California, Berkeley Bachelor of Arts (B.A.) Mathematics
Vrije Universiteit Amsterdam Doctor of Philosophy (PhD) Statistical Genetics